The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksImperial Innovations Group Regulatory News (IVO)

  • There is currently no data for IVO

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Investment in new technology company

14 Feb 2013 07:00

RNS Number : 8438X
Imperial Innovations Group plc
14 February 2013
 



14 February 2013

 

Imperial Innovations Group plc

 

Innovations invests £0.5m in new company, Impression Technologies

 

Imperial Innovations Group plc (AIM: IVO, 'Innovations'), a leading technology commercialisation and investment group, has invested £0.5m in Impression Technologies, an aluminium forming technology business based on intellectual property developed at Imperial College London. The new funds will be used to support the development of its aluminium forming process, manufacture demonstration parts and develop a technical and commercial team.

 

The world's automotive and transport industries will have to make a step change in their use of aluminium if they are to meet the environmental challenges of reducing energy consumption and carbon emission targets. Aluminium is difficult to form into complex shapes due to its limited ductility. Current technologies cannot meet the challenges faced in producing sophisticated shapes and structures for high volume applications cost effectively.

 

Professor Lin of Imperial College London and Professor Dean of the University of Birmingham, have developed the Hot Form Quench (HFQ) technology, which provides a cost-competitive means of producing lightweight, complex and structured aluminium components, and opens the door to a new generation of solutions for the automotive, aerospace and rail industries. Impression Technologies has been created to commercialise this technology and its associated know-how.

 

In the patented HFQ process, an aluminium sheet is heated above its Solution Heat Treatment temperature, formed while hot, and quenched in the press. This process allows pressings to be formed which are lighter, deeper and with tighter radii than has been possible to date. The process is quicker and more cost-effective than current methods, results in superior metallurgical properties, and allows stronger and lighter structures to be formed.

 

The market for passenger car vehicles alone is some 60 million vehicles a year, and the opportunity for components which might be formed using this technology is of the order of €10 billion per annum globally in passenger cars alone. Impression Technologies is in talks with a range of potential partners with which it expects to enter into trading, licensing and partnering arrangements.

 

Impression Technologies is headed by CEO George Adam, an experienced automotive manager with over 30 years' experience at GKN plc and ESAB China, and Chairman Mike Foster, formerly CEO of Charter International plc, which he headed for 5 years following a career at GKN plc and Kvaener.

 

Susan Searle, Chief Executive Officer, Imperial Innovations, said:

 

"Impression Technologies is an example of the support Innovations offers in the commercialisation of new technologies developed at Imperial College London, which have the ability to transform the way industries operate. The deployment of HFQ technology has great commercial and environmental potential."

 

George Adam, Chief Executive Officer of Impression Technologies, said:

 

"HFQ enables the production of lighter, stronger and more sophisticated structures in Aluminium than has been possible to date cost-effectively. It creates new opportunities for car manufacturers and others to improve the performance of their vehicles while reducing their carbon footprint."

 

Enquiries:

Imperial Innovations

+44 (0)20 7581 4949

Susan Searle, Chief Executive Officer

Terry Nicklin, Director of Communications

Gavin Reed, Marketing Assistant

College Hill

+44 (0)20 7457 2020

Adrian Duffield/Rozi Morris/Melanie Toyne-Sewell/Tim Watson

 

Notes to editors

 

Imperial Innovations - www.imperialinnovations.co.uk 

 

Innovations creates, builds and invests in pioneering university technologies addressing global problems in healthcare, energy, engineering and the environment. It combines deep understanding of science and technology with commercial acumen and strong investment expertise.

 

Innovations supports scientist-entrepreneurs in the commercialisation of their ideas by:

 

·; leading the formation of new companies and providing facilities in the early stages

·; providing significant investment and encouraging co-investment to accelerate the transition from R&D to products

·; providing operational expertise

·; helping to recruit high-calibre industry figures and experienced entrepreneurs as executive management and Board members

 

Innovations invests in companies based on technologies from or associated with four universities: Imperial College London; and Cambridge University, Oxford University, and UCL supported by its collaborations with Cambridge Enterprise, OSEM and UCL Business. These are the UK's leading research intensive universities, measured by research income.

 

By raising £140 million in January 2011, Innovations has been able to accelerate the making of, and increase the size of its investments. In the year to 31 July 2012, Innovations invested £37.9 million (2011: £35.1 million) in 29 ventures, and made 11 investments in new companies.

 

In its current portfolio of 78 companies, Innovations' most advanced assets include Circassia, which develops innovative vaccines for the treatment of a wide range of allergies; and Nexeon, a battery materials and licensing company which develops silicon anodes which extend the life and increase the capacity of lithium-ion batteries.

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRABIGDDXUBBGXX
Date   Source Headline
27th Nov 20177:00 amRNSExercise of share options
27th Nov 20177:00 amRNSIssue of Equity
13th Nov 20177:01 amRNSBoard changes following cancellation of admission
13th Nov 20177:00 amRNSNotice of cancellation of admission to AIM
27th Oct 201710:54 amRNSPosting of Annual Report
26th Oct 20173:50 pmRNSIssue of Equity
18th Oct 201710:30 amRNSOffer Update; Appointment of Prof. David Begg
18th Oct 20179:38 amRNSUpdated recommendation by Touchstone Innovations
18th Oct 20177:00 amRNSOffer Update - Wholly Unconditional
17th Oct 20179:10 amRNSGrant of share options
17th Oct 20177:36 amRNSOffer Update - CMA clearance and Offer timetable
16th Oct 201710:54 amRNSForm 8.5 (EPT/RI) - Touchstone Innovations Plc
9th Oct 20179:58 amRNSForm 8.5 (EPT/RI) - Touchstone Innovations Plc
9th Oct 20177:00 amRNSOffer Update
5th Oct 20178:30 amRNSForm 8.5 (EPT/RI) - Touchstone Innovations Plc
4th Oct 20177:00 amRNSTouchstone invests £1.4m in Featurespace round
2nd Oct 201710:32 amRNSForm 8.5 (EPT/RI) - Touchstone Innovations Plc
29th Sep 20178:29 amRNSForm 8.5 (EPT/RI) - Touchstone Innovations Plc
25th Sep 20179:15 amRNSForm 8.5 (EPT/RI) - Touchstone Innovations Plc
21st Sep 20178:56 amRNSForm 8.5 (EPT/RI) - Touchstone Innovations Plc
18th Sep 20177:00 amRNSOffer Update
13th Sep 20179:33 amRNSForm 8.5 (EPT/RI) - Touchstone Innovations Plc
13th Sep 20177:00 amRNSFinal Results
12th Sep 20171:48 pmRNSForm 8.3 - Touchstone Innovations plc
12th Sep 20171:46 pmRNSForm 8.3 - Touchstone Innovations plc
12th Sep 201711:50 amRNSForm 8.3 - Touchstone Innovations Plc
12th Sep 201710:52 amRNSForm 8.5 (EPT/RI) - Touchstone Innovations Plc
12th Sep 20177:00 amRNSTouchstone commits funds to Ieso Digital Health
11th Sep 20179:41 amRNSForm 8.5 (EPT/RI) - Touchstone Innovations Plc
8th Sep 20173:20 pmRNSForm 8.3 - Touchstone Innovations PLC
8th Sep 20178:51 amRNSForm 8.5 (EPT/RI) - Touchstone Innovations PLC
7th Sep 20173:20 pmRNSForm 8.3 - Touchstone Innovations PLC
7th Sep 20178:57 amRNSForm 8.5 (EPT/RI) - Touchstone Innovations PLC
30th Aug 20176:21 pmRNSUpdate on Offer for Touchstone Innovations plc
25th Aug 201710:14 amRNSUpdate on Offer for Touchstone and Capital Raising
25th Aug 20179:56 amRNSStatement re: Offer timetable extended
21st Aug 20173:20 pmRNSForm 8.3 - Touchstone Innovations PLC
17th Aug 20177:00 amRNSFurther re Capital Raising
16th Aug 20173:12 pmRNSForm 8.3 - IP Group Plc
15th Aug 20173:20 pmRNSForm 8.3 - Touchstone Innovations PLC
1st Aug 20177:00 amRNSPublication of Response Circular
28th Jul 20172:21 pmRNSForm 8.3 - IP Group Plc
27th Jul 20172:52 pmRNSForm 8.3 - IP Group Plc
26th Jul 20172:20 pmRNSForm 8.3 - IP Group Plc
25th Jul 20175:38 pmRNSStatement re clarification of offer for Touchstone
25th Jul 201712:16 pmRNSForm 8.3 - Touchstone Innovations Plc
21st Jul 201712:43 pmRNSForm 8.3 - Touchstone Innovations Plc
20th Jul 201711:35 amRNSForm 8.5 (EPT/RI) - Touchstone Innovations Plc
19th Jul 201711:42 amRNSForm 8.5 (EPT/RI) - Touchstone Innovations Plc
19th Jul 201711:14 amRNSForm 8.3 - Touchstone Innovations Plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.